These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 9587138

  • 1. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL, Klomp LW, Gitlin JD.
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [Abstract] [Full Text] [Related]

  • 2. Aceruloplasminemia.
    Kono S.
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [Abstract] [Full Text] [Related]

  • 3. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X, Pin S, Gathinji M, Fuchs R, Harris ZL.
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [Abstract] [Full Text] [Related]

  • 4. Ceruloplasmin metabolism and function.
    Hellman NE, Gitlin JD.
    Annu Rev Nutr; 2002 Mar; 22():439-58. PubMed ID: 12055353
    [Abstract] [Full Text] [Related]

  • 5. Aceruloplasminemia: an update.
    Kono S.
    Int Rev Neurobiol; 2013 Mar; 110():125-51. PubMed ID: 24209437
    [Abstract] [Full Text] [Related]

  • 6. [Aceruloplasminemia].
    Miyajima H.
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [Abstract] [Full Text] [Related]

  • 7. The copper-iron connection: hereditary aceruloplasminemia.
    Nittis T, Gitlin JD.
    Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
    [Abstract] [Full Text] [Related]

  • 8. Aceruloplasminemia.
    Gitlin JD.
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [Abstract] [Full Text] [Related]

  • 9. Ceruloplasmin in neurodegenerative diseases.
    Vassiliev V, Harris ZL, Zatta P.
    Brain Res Brain Res Rev; 2005 Nov; 49(3):633-40. PubMed ID: 16269323
    [Abstract] [Full Text] [Related]

  • 10. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux.
    Harris ZL, Durley AP, Man TK, Gitlin JD.
    Proc Natl Acad Sci U S A; 1999 Sep 14; 96(19):10812-7. PubMed ID: 10485908
    [Abstract] [Full Text] [Related]

  • 11. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
    Harris ZL, Takahashi Y, Miyajima H, Serizawa M, MacGillivray RT, Gitlin JD.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2539-43. PubMed ID: 7708681
    [Abstract] [Full Text] [Related]

  • 12. Biochemical analysis of a missense mutation in aceruloplasminemia.
    Hellman NE, Kono S, Miyajima H, Gitlin JD.
    J Biol Chem; 2002 Jan 11; 277(2):1375-80. PubMed ID: 11689569
    [Abstract] [Full Text] [Related]

  • 13. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
    Finkenstedt A, Wolf E, Höfner E, Gasser BI, Bösch S, Bakry R, Creus M, Kremser C, Schocke M, Theurl M, Moser P, Schranz M, Bonn G, Poewe W, Vogel W, Janecke AR, Zoller H.
    J Hepatol; 2010 Dec 11; 53(6):1101-7. PubMed ID: 20801540
    [Abstract] [Full Text] [Related]

  • 14. Aceruloplasminemia, an inherited disorder of iron metabolism.
    Miyajima H, Takahashi Y, Kono S.
    Biometals; 2003 Mar 11; 16(1):205-13. PubMed ID: 12572680
    [Abstract] [Full Text] [Related]

  • 15. Aceruloplasminemia.
    Miyajima H.
    Neuropathology; 2015 Feb 11; 35(1):83-90. PubMed ID: 25168455
    [Abstract] [Full Text] [Related]

  • 16. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H, Reynaud Q, Mainbourg S, Lega JC, Durieu I, Durupt S.
    Rev Med Interne; 2020 Nov 11; 41(11):769-775. PubMed ID: 32682623
    [Abstract] [Full Text] [Related]

  • 17. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M, Marchi G, Barqué A, Esteban-Jurado C, Marchetto A, Giorgetti A, Chelban V, Houlden H, Wood NW, Piubelli C, Dorigatti Borges M, Martins de Albuquerque D, Yotsumoto Fertrin K, Jové-Buxeda E, Sanchez-Delgado J, Baena-Díez N, Burnyte B, Utkus A, Busti F, Kaubrys G, Suku E, Kowalczyk K, Karaszewski B, Porter JB, Pollard S, Eleftheriou P, Bignell P, Girelli D, Sanchez M.
    Int J Mol Sci; 2020 Mar 30; 21(7):. PubMed ID: 32235485
    [Abstract] [Full Text] [Related]

  • 18. Molecular and pathological basis of aceruloplasminemia.
    Kono S, Miyajima H.
    Biol Res; 2006 Mar 30; 39(1):15-23. PubMed ID: 16629161
    [Abstract] [Full Text] [Related]

  • 19. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A, Conti A, Cremonesi M, D'Adamo P, Gilberti E, Apostoli P, Cannistraci CV, Piperno A, David S, Alessio M.
    EMBO Mol Med; 2018 Jan 30; 10(1):91-106. PubMed ID: 29183916
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma lipid peroxidation in patients with aceruloplasminemia.
    Miyajima H, Takahashi Y, Serizawa M, Kaneko E, Gitlin JD.
    Free Radic Biol Med; 1996 Jan 30; 20(5):757-60. PubMed ID: 8721620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.